153 results for "Features"
21 December 2020
Three A*STAR scholars—Sarah Luo, Caroline Wee, and Kaicheng Liang—have been selected for the highly competitive National Research Foundation Fellowship out of over 134 applicants worldwide.
18 December 2020
From genomics to gene editing and cancer research, the A*STAR winners of the 2020 President’s Science and Technology Awards and Young Scientist Awards are blazing the trail in biological research.
20 November 2020
Computing devices are finally reaching their limits. But recently discovered particles called magnetic skyrmions could redefine these limits, according to Anjan Soumyanarayanan.
6 November 2020
A*STAR researchers have developed a point-of-care rapid antibody test kit that can detect antibodies produced in response to SARS-CoV-2 infection in just fifteen minutes.
30 October 2020
Multidimensional emotion-sensing algorithms that analyze social media for the public’s concerns during times of crisis could help improve policy and messaging from governments.
23 October 2020
By eliminating bottlenecks and automating manual processes, the RESOLUTE test kit and RAVE system co-developed by A*STAR scientists will help give COVID-19 testing a much-needed boost.
12 October 2020
In the search for new therapeutics and diagnostic tools, Sherry Aw is unraveling the biology behind movement disorders using the humble fruit fly.
11 September 2020
Could there be a drug that can both treat and protect against COVID-19? The answer may be found in antibody drugs, a promising therapeutic modality against the coronavirus.
9 September 2020
A new test manufactured by A*STAR’s Diagnostics Development Hub in partnership with Duke-NUS Medical School could reveal if an individual is likely immune to COVID-19.
4 September 2020
Sebastian Maurer-Stroh shares how bioinformatics has enabled Singapore to respond quickly to COVID-19 and will continue to play an important role in ongoing surveillance.
24 August 2020
Scientists at A*STAR have found that a mutation in SARS-CoV-2 called ∆382 leads to milder clinical outcomes, with implications for COVID-19 treatments and vaccines.